(Q45302732)

11 December 2017

LRRK2 expression in normal and pathologic human brain and in human cell lines (English)

1 reference

11 December 2017

Judith Miklossy

1

0 references

author name string

Tetsuaki Arai

2

1 reference

11 December 2017

Jian-Ping Guo

3

1 reference

11 December 2017

Andis Klegeris

4

1 reference

11 December 2017

Sheng Yu

5

1 reference

11 December 2017

Edith G McGeer

6

1 reference

11 December 2017

Patrick L McGeer

7

1 reference

11 December 2017

1 October 2006

1 reference

Journal of Neuropathology & Experimental Neurology

11 December 2017

1 reference

11 December 2017

65

1 reference

11 December 2017

953-963

1 reference

11 December 2017

10

1 reference

Genetics of Parkinsonism: a review

11 December 2017

1 reference

12 December 2020

Roc, a Ras/GTPase domain in complex proteins

1 reference

12 December 2020

Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease

1 reference

12 December 2020

Induction of complement C9 messenger RNAs in human neuronal cells by inflammatory stimuli: relevance to neurodegenerative disorders

1 reference

12 December 2020

Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology

1 reference

12 December 2020

Biochemical and pathological characterization of Lrrk2.

1 reference

12 December 2020

Retinoic acid-induced differentiation of cultured human neuroblastoma cells: a comparison with phorbolester-induced differentiation

1 reference

12 December 2020

Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations

1 reference

12 December 2020

Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity

1 reference

12 December 2020

Isolation and characterization of adult microglial cells and oligodendrocytes derived from postmortem human brain tissue.

1 reference

12 December 2020

Anatomical localization of leucine-rich repeat kinase 2 in mouse brain.

1 reference

12 December 2020

LRRK2 haplotype analyses in European and North African families with Parkinson disease: a common founder for the G2019S mutation dating from the 13th century

1 reference

12 December 2020

SARS corona virus peptides recognized by antibodies in the sera of convalescent cases

1 reference

12 December 2020

An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family.

1 reference

12 December 2020

LRRK2 expression linked to dopamine-innervated areas.

1 reference

12 December 2020

Aetiology of Parkinson's disease

1 reference

12 December 2020

Familial Parkinson's disease: possible role of environmental factors

1 reference

12 December 2020

A susceptibility locus for Parkinson's disease maps to chromosome 2p13.

1 reference

12 December 2020

Genetic and environmental factors in the cause of Parkinson's disease

1 reference

12 December 2020

New genetic insights into Parkinson's disease

1 reference

12 December 2020

Expression of complement messenger RNAs and proteins by human oligodendroglial cells.

1 reference

12 December 2020

The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity

1 reference

12 December 2020

Parkinson's disease. Genetic analysis and evidence of a multifactorial etiology

1 reference

12 December 2020

Human oligodendroglial cells express low levels of C1 inhibitor and membrane cofactor protein mRNAs

1 reference

12 December 2020

Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease.

1 reference

12 December 2020

LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews.

1 reference

12 December 2020

LRRK2 is expressed in areas affected by Parkinson's disease in the adult mouse brain.

1 reference

12 December 2020

10.1097/01.JNEN.0000235121.98052.54

Identifiers

DOI

1 reference

11 December 2017

0 references

1 reference